Hawthorne Medical Research, Inc Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2008
NCT00786188
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Hawthorne Medical Research, Inc., Greensboro, NC 27408 | Hawthorne Medical Research, Inc., Winston-Salem, NC 27103

Active Ingredients

Drugs in Phase 3 Trials (1)

paroxetine (paxil) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hot Flashes (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1